S&P 및 Nasdaq 내재가치 문의하기
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 전체 종목으로

Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
$37.40
-8.4%
Analyst Price Target
$33.50
-18%

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

지표 Latest Quarter (2025-12)
총자산 $1.08B
Total Liabilities $705.11M
총부채 $486.31M
Cash & Investments $467.76M
주주자본 합계 $370.15M

다른 사용자도 조회

MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 RXDX
RXDX
Prometheus Biosciences, Inc.
$199.92
+0.09%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
 IMVT
IMVT
Immunovant, Inc.
$26.55
+5.69%
 TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
 AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
 MRTX
MRTX
Mirati Therapeutics, Inc.
$58.70
-0.17%
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
📧 [email protected]
📞 +65 8912 8000
메시지 보내기